Compare DLHC & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLHC | PAVM |
|---|---|---|
| Founded | 1969 | 2014 |
| Country | United States | United States |
| Employees | 2300 | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.9M | 41.1M |
| IPO Year | 2012 | 2015 |
| Metric | DLHC | PAVM |
|---|---|---|
| Price | $2.88 | $1.20 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.50 |
| AVG Volume (30 Days) | 9.2K | ★ 21.2K |
| Earning Date | 12-09-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,923,000.00 | $3,000,000.00 |
| Revenue This Year | N/A | $227.46 |
| Revenue Next Year | N/A | $158.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 2.57 | ★ 20.00 |
| 52 Week Low | $2.86 | $0.21 |
| 52 Week High | $6.88 | $38.99 |
| Indicator | DLHC | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 23.12 | 28.22 |
| Support Level | N/A | $1.17 |
| Resistance Level | $4.05 | $6.56 |
| Average True Range (ATR) | 0.20 | 0.26 |
| MACD | -0.08 | 0.03 |
| Stochastic Oscillator | 0.90 | 8.93 |
DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.